logo

For the Inventor, By the Inventor

Taipei, Taiwan

Allgenesis Biotherapeutics Inc.


USPTO Granted Patents = 9


Trademarks = 2

Forward Citations = 13

Loading Chart...
Loading Chart...

24 inventors (with patents filed for the assignee):

goldMedal Tan Nguyen (7 out of 7 patents)

silverMedal Pei-Tzu Wu (5 out of 5 patents)

bronzeMedal Chin-Yu Lai (3 out of 3 patents)

4.  Kevin Zen (3 out of 3 patents)

5.  Madhu Cherukury (3 out of 3 patents)

6.  Jia-Hau Shiu (2 out of 2 patents)

7.  Yung-Sheng Chang (2 out of 4 patents)

8.  Madhu Cherukury (2 out of 2 patents)

9.  Huang-Tsu Chen (1 out of 6 patents)

10.  Jiun-Shyang Leou (1 out of 4 patents)

11.  Ching-Hsuan Hsu (1 out of 6 patents)

12.  Fei Liu (1 out of 10 patents)

13.  Cuixia Zhang (1 out of 3 patents)

14.  Weiming Jiang (1 out of 3 patents)

15.  Haolong Zhang (1 out of 1 patent)


9 patents:

1. 12318428 - VEGFR fusion protein pharmaceutical composition (2025-06-03),
2. 12152057 - Fusion proteins for inhibiting angiogenesis (2024-11-26),
3. 11723955 - VEGFR fusion protein pharmaceutical composition (2023-08-15),
4. 11369600 - Ophthalmic formulations of tyrosine kinase inhibitors, methods of use thereof, and preparation methods thereof (2022-06-28),
5. 11299531 - Fusion protein comprising a ligand binding domain of VEGF and PDGF (2022-04-12),
6. 11192927 - Fusion proteins for inhibiting angiogenesis (2021-12-07),
7. 10961203 - Crystalline forms of 3-Z-[1-(4-(N-((4-methyl-piperazin-1-yl)-methylcarbonyl)-N-methyl-amino)-phenylamino)-1-phenyl-methylene]-6-methoxycarbonyl-2-indolinone (2021-03-30),
8. 10870635 - Compounds and their use as BACE1 inhibitors (2020-12-22),
9. 10154994 - Ophthalmic formulations of tyrosine kinase inhibitors, methods of use thereof, and preparation methods thereof (2018-12-18),
Company Overview
Allgenesis Biotherapeutics Inc. is a biotechnology company specializing in the development of innovative therapies for serious diseases. Our research focuses on leveraging cutting-edge technologies to create breakthrough treatments that address unmet medical needs. We are committed to advancing the field of biotechnology and improving the lives of patients worldwide.
Profile summary synthesized from public USPTO records and patent filings.

logo

Company Badge

USPTO Data Jan 1 1976 - Oct 20 2026

9 Patents

#440 in Taipei

#1,550 in Taiwan

Taipei, TW
Taipei, Taiwan

Allgenesis Biotherapeutics Inc.

Forward Citations = 13

24 inventors:

goldMedal Tan Nguyen (7 out of 7 patents)

silverMedal Pei-Tzu Wu (5 out of 5 patents)

bronzeMedal Chin-Yu Lai (3 out of 3 patents)

4.  Kevin Zen (3 out of 3 patents)

5.  Madhu Cherukury (3 out of 3 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Allgenesis Biotherapeutics Inc.. Retrieved from https://idiyas.com/company/allgenesis-biotherapeutics

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…